ALB and hepatocellular carcinoma: The significant factors identified by univariate analysis for stage B HCC patient recurrence were included in multivariate analysis which showed that the lower serum albumin level (p = 0.026), PIVKA-II (100–1000 vs >1000, p = 0.038; 100–1000 vs ≤100, p = 0.002), AP-factor (AP1 vs AP2, p = 0.0036; AP2 vs AP3, p = 0.001), tumor number (1 vs 2 or 3, p = 0.037; 1 vs ≥4, p < 0.001) and microscopic portal vein invasion (vp0 vs vp2, p = 0.006) (Table 3).